Cardioprotective Effects of Hydrogen Sulfide and Its Potential Therapeutic Implications in the Amelioration of Duchenne Muscular Dystrophy Cardiomyopathy

被引:2
|
作者
Loboda, Agnieszka [1 ]
Dulak, Jozef [1 ]
机构
[1] Jagiellonian Univ Krakow, Fac Biochem Biophys & Biotechnol, Dept Med Biotechnol, Gronostajowa 7 St, PL-30387 Krakow, Poland
关键词
Duchenne muscular dystrophy; DMD; cardiomyopathy; iPSC-CM; induced pluripotent stem cell-derived cardiomyocytes; hydrogen sulfide; H2S; DOXORUBICIN-INDUCED CARDIOTOXICITY; CONVERTING ENZYME-INHIBITORS; GLUCOSE-INDUCED APOPTOSIS; INDUCED HEART-FAILURE; S-PROPARGYL-CYSTEINE; K-ATP CHANNELS; REPERFUSION INJURY; MYOCARDIAL-INFARCTION; INDUCED INFLAMMATION; CARDIAC DYSFUNCTION;
D O I
10.3390/cells13020158
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Hydrogen sulfide (H2S) belongs to the family of gasotransmitters and can modulate a myriad of biological signaling pathways. Among others, its cardioprotective effects, through antioxidant, anti-inflammatory, anti-fibrotic, and proangiogenic activities, are well-documented in experimental studies. Cardiorespiratory failure, predominantly cardiomyopathy, is a life-threatening complication that is the number one cause of death in patients with Duchenne muscular dystrophy (DMD). Although recent data suggest the role of H2S in ameliorating muscle wasting in murine and Caenorhabditis elegans models of DMD, possible cardioprotective effects have not yet been addressed. In this review, we summarize the current understanding of the role of H2S in animal models of cardiac dysfunctions and cardiac cells. We highlight that DMD may be amenable to H2S supplementation, and we suggest H2S as a possible factor regulating DMD-associated cardiomyopathy.
引用
收藏
页数:30
相关论文
共 50 条
  • [31] Circadian Clock in Muscle Disease Etiology and Therapeutic Potential for Duchenne Muscular Dystrophy
    Kiperman, Tali
    Ma, Ke
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (09)
  • [32] Striking Cardioprotective Effects of an Adiponectin Receptor Agonist in an Aged Mouse Model of Duchenne Muscular Dystrophy
    Abou-Samra, Michel
    Dubuisson, Nicolas
    Marino, Alice
    Selvais, Camille M.
    Romain, Versele
    Davis-Lopez de Carrizosa, Maria A.
    Noel, Laurence
    Beauloye, Christophe
    Brichard, Sonia M.
    Horman, Sandrine
    ANTIOXIDANTS, 2024, 13 (12)
  • [33] Hydrogen Sulfide Improves Aberrant Gastric Smooth Muscle Function in Duchenne Muscular Dystrophy Mice
    Randhawa, Gurpreet
    Singh, Kulpreet
    Mahavadi, Sunila
    Cain, Chad
    Salloum, Fadi N.
    Murthy, Karnam S.
    Grider, John R.
    FASEB JOURNAL, 2019, 33
  • [34] Re-examination of the Electrocardiogram in Boys With Duchenne Muscular Dystrophy and Correlation With Its Dilated Cardiomyopathy
    Thrush, Philip T.
    Allen, Hugh D.
    Viollet, Laurence
    Mendell, Jerry R.
    AMERICAN JOURNAL OF CARDIOLOGY, 2009, 103 (02): : 262 - 265
  • [35] Mitochondrial hydrogen sulfide supplementation improves health in the C. elegans Duchenne muscular dystrophy model
    Ellwood, Rebecca A.
    Hewitt, Jennifer E.
    Torregrossa, Roberta
    Philp, Ashleigh M.
    Hardee, Justin P.
    Hughes, Samantha
    van de Klashorst, David
    Gharahdaghi, Nima
    Anupom, Taslim
    Slade, Luke
    Deane, Colleen S.
    Cooke, Michael
    Etheridge, Timothy
    Piasecki, Mathew
    Antebi, Adam
    Lynch, Gordon S.
    Philp, Andrew
    Vanapalli, Siva A.
    Whiteman, Matthew
    Szewczyk, Nathaniel J.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2021, 118 (09)
  • [36] Effects of cardiac medications on ventricular function in patients with Duchenne muscular dystrophy-related cardiomyopathy
    Murphy, Alexander P.
    Johnson, Anna
    Straub, Volker
    Heads-Baister, Alison
    Lord, Stephen
    Bourke, John P.
    MUSCLE & NERVE, 2021, 64 (02) : 163 - 171
  • [37] Effects of Angiotensin-Converting Enzyme Inhibitors and/or Beta Blockers on the Cardiomyopathy in Duchenne Muscular Dystrophy
    Viollet, Laurence
    Thrush, Philip T.
    Flanigan, Kevin M.
    Mendell, Jerry R.
    Allen, Hugh D.
    AMERICAN JOURNAL OF CARDIOLOGY, 2012, 110 (01): : 98 - 102
  • [38] Exploring the Therapeutic Potential of Ectoine in Duchenne Muscular Dystrophy: Comparison with Taurine, a Supplement with Known Beneficial Effects in the mdx Mouse
    Merckx, Caroline
    Zschuentzsch, Jana
    Meyer, Stefanie
    Raedt, Robrecht
    Verschuere, Hanne
    Schmidt, Jens
    De Paepe, Boel
    De Bleecker, Jan L.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (17)
  • [39] Evaluation of the potential therapeutic use of immature stem cells in a canine model for Duchenne muscular dystrophy
    Ambrosio, C. E.
    Kerkis, I.
    Martins, D. S.
    Kerkis, A.
    Vanizof, M.
    Fonseca, S. A. S.
    Maranduba, C.
    Cabral, R. M.
    Peixoto, T. G.
    Morini, A. C.
    Brolio, M. P.
    Bertolini, L. R.
    Miglino, M. A.
    Zatz, M.
    PLACENTA, 2007, 28 (8-9) : A19 - A19
  • [40] Elucidating the Role of Mineralocorticoid Receptors in Skeletal Muscle as a Potential Therapeutic Target for Duchenne Muscular Dystrophy
    Chadwick, Jessica
    Hauck, James
    Lowe, Jeovanna
    Rafael-Fortney, Jill
    FASEB JOURNAL, 2015, 29